Topoisomerase II inhibition is a mechanism used by certain anticancer drugs to prevent DNA replication and transcription by stabilizing the transient double-strand breaks introduced by the enzyme, ultimately leading to cell death. This process is crucial in cancer therapy as it targets rapidly dividing tumor cells, but it can also affect normal cells, leading to potential side effects.